Clinical Trial Update: Midodrine as Novel Treatment of Post-Cardiopulmonary Bypass Vasoplegic Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial update on midodrine for post-cardiopulmonary bypass vasoplegic syndrome; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-cardiopulmonary Bypass Vasoplegic Syndrome

Drugs mentioned

• Midodrine (Midodrine)

Snippet

Sponsor: Medstar Health Research Institute | Conditions: Use of Midodrine in Post-cardiopulmonary Bypass Vasoplegic Syndrome | Phase 4 | Status: TERMINATED